Results for tag: "Levosimendan"

Levosimendan is a calcium sensitizer used in the treatment of acute heart failure. It is a vasodilator that increases the contractility of the heart muscle without increasing oxygen demand. It is used to reduce the risk of death in patients with acute heart failure and to improve symptoms such as shortness of breath. It is also used to reduce the risk of death in patients with severe left ventricular dysfunction. Levosimendan is a relatively new drug in the cardiovascular drugs market, but it has been gaining traction in recent years. It is approved for use in many countries, including the United States, Europe, and Japan. It is available in both intravenous and oral formulations. The market for levosimendan is highly competitive, with several major pharmaceutical companies competing for market share. Some of the major players in the market include AstraZeneca, Bayer, GlaxoSmithKline, Novartis, Pfizer, and Sanofi. Show Less Read more